FDA CONSUMER HEALTH INFORMATION: Seven Inhalers That Use CFCs Being Phased Out
SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ — The Food and Drug Administration (FDA) says that seven metered dose inhalers that contain chlorofluorocarbons (CFCs) are being phased out in the United States.
These inhalers use CFCs as propellants to spray the medicine out of the inhaler so patients can breathe the medicine into their lungs. They’re used for the treatment of asthma or chronic obstructive pulmonary disease (COPD) or both.
Learn more about the phase-out — and about other available inhalers that do not contain CFCs — at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm207864.
Sign up for e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit “FDA Consumer Health Information (www.fda.gov/consumer)” as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: firstname.lastname@example.org.
CONTACT: Jason Brodsky, +1-301-827-6251, email@example.com
SOURCE U.S. Food and Drug Administration